Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Huber

Showing results (181-190 of 433) with videos related to

Pageof 44
Sort By:
Acta Medica Austriaca|January 1, 1987
[Objective tissue differentiation in sonography using local texture analysis]E Schuster, P Knoflach, C Kratzik, et al.
Wiener Klinische Wochenschrift|November 22, 2001
[Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage]K el-Rabadi, M Gottsauner-Wolf, G Christ, et al.
Contributions to Nephrology|January 1, 1985
Optimising of hemodiafiltration with modern membranes?K G Sprenger, H Stephan, W Kratz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 22, 2010
Evaluation of the particle growth of amorphous calcium carbonate in water by means of the Porod invariant from SAXSJ Liu, S Pancera, V Boyko, et al.
Annals of the New York Academy of Sciences|February 24, 2001
Epithelial phosphate transporters in small ruminantsK Huber, C Walter, B Schröder, et al.
Herz|October 28, 2016
[Cardioprotection via the arm? : How a blood pressure cuff decreases infarct sizes]P M Haller, A Kiss, J Wojta, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Thrombolysis of acute myocardial infarct: modifying factors of "door-to-needle time"]W Schreiber, M Brunner, W Hödl, et al.
European Journal of Clinical Investigation|December 1, 1988
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluidK Huber, J Wojta, J C Kirchheimer, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2016
An emerging role for eotaxins in neurodegenerative diseaseAmanda K Huber, David A Giles, Benjamin M Segal, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Immunophenotyping of leukemia: overview]K Huber, B Worofka, E Kittl, et al.
Pageof 44

Showing results (181-190 of 433) with videos related to

Sort By:
Pageof 44
Acta Medica Austriaca|January 1, 1987
[Objective tissue differentiation in sonography using local texture analysis]E Schuster, P Knoflach, C Kratzik, et al.
Wiener Klinische Wochenschrift|November 22, 2001
[Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage]K el-Rabadi, M Gottsauner-Wolf, G Christ, et al.
Contributions to Nephrology|January 1, 1985
Optimising of hemodiafiltration with modern membranes?K G Sprenger, H Stephan, W Kratz, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|October 22, 2010
Evaluation of the particle growth of amorphous calcium carbonate in water by means of the Porod invariant from SAXSJ Liu, S Pancera, V Boyko, et al.
Annals of the New York Academy of Sciences|February 24, 2001
Epithelial phosphate transporters in small ruminantsK Huber, C Walter, B Schröder, et al.
Herz|October 28, 2016
[Cardioprotection via the arm? : How a blood pressure cuff decreases infarct sizes]P M Haller, A Kiss, J Wojta, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Thrombolysis of acute myocardial infarct: modifying factors of "door-to-needle time"]W Schreiber, M Brunner, W Hödl, et al.
European Journal of Clinical Investigation|December 1, 1988
Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluidK Huber, J Wojta, J C Kirchheimer, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2016
An emerging role for eotaxins in neurodegenerative diseaseAmanda K Huber, David A Giles, Benjamin M Segal, et al.
Wiener Klinische Wochenschrift|January 1, 1994
[Immunophenotyping of leukemia: overview]K Huber, B Worofka, E Kittl, et al.
Pageof 44